Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 23
1987 77
1988 67
1989 75
1990 85
1991 81
1992 105
1993 117
1994 89
1995 103
1996 114
1997 130
1998 151
1999 141
2000 152
2001 111
2002 131
2003 136
2004 127
2005 126
2006 149
2007 127
2008 162
2009 136
2010 135
2011 145
2012 184
2013 178
2014 160
2015 171
2016 158
2017 182
2018 184
2019 167
2020 221
2021 210
2022 242
2023 180
2024 114

Text availability

Article attribute

Article type

Publication date

Search Results

4,974 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Early Treatment with Ivermectin among Patients with Covid-19.
Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, Campos VHS, Nogueira AMR, de Almeida APFG, Callegari ED, Neto ADF, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Rowland-Yeo K, Guyatt GH, Boulware DR, Rayner CR, Mills EJ; TOGETHER Investigators. Reis G, et al. N Engl J Med. 2022 May 5;386(18):1721-1731. doi: 10.1056/NEJMoa2115869. Epub 2022 Mar 30. N Engl J Med. 2022. PMID: 35353979 Free PMC article. Clinical Trial.
Ivermectin for COVID-19: The 2022 Update.
Manu P. Manu P. Am J Ther. 2022 Nov-Dec 01;29(6):e647-e648. doi: 10.1097/MJT.0000000000001577. Am J Ther. 2022. PMID: 36608065 No abstract available.
Ivermectin.
Elgart GW, Meinking TL. Elgart GW, et al. Dermatol Clin. 2003 Apr;21(2):277-82. doi: 10.1016/s0733-8635(02)00095-5. Dermatol Clin. 2003. PMID: 12757250 Review.
Ivermectin for preventing and treating COVID-19.
Popp M, Reis S, Schießer S, Ilona Hausinger R, Stegemann M, Metzendorf MI, Kranke P, Meybohm P, Skoetz N, Weibel S. Popp M, et al. Emergencias. 2023 Oct;35(5):381-383. doi: 10.55633/s3me/E029.2023. Emergencias. 2023. PMID: 37801420 English, Spanish. No abstract available.
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Slandzicki AJ, Lim SC, Cohen J, Kavtaradze D, Amon AP, Gabriel A, Gentile N, Felker GM, Jayaweera D, McCarthy MW, Sulkowski M, Rothman RL, Wilson S, DeLong A, Remaly A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Thicklin F, Hanna GJ, Ginde AA, Castro M, McTigue K, Shenkman E, Hernandez AF; Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Naggie S, et al. JAMA. 2023 Mar 21;329(11):888-897. doi: 10.1001/jama.2023.1650. JAMA. 2023. PMID: 36807465 Free PMC article.
Ivermectin and the Emergence of Long COVID.
Manu P. Manu P. Am J Ther. 2023 Mar-Apr 01;30(2):e145. doi: 10.1097/MJT.0000000000001607. Epub 2023 Feb 10. Am J Ther. 2023. PMID: 36762927 No abstract available.
[Ivermectin].
Develoux M. Develoux M. Ann Dermatol Venereol. 2004 Jun-Jul;131(6-7 Pt 1):561-70. doi: 10.1016/s0151-9638(04)93668-x. Ann Dermatol Venereol. 2004. PMID: 15318139 Review. French.
Ivermectin: a pathway out of the pandemic or another dead end?
Echeverría-Esnal D, Grau S. Echeverría-Esnal D, et al. Expert Rev Anti Infect Ther. 2022 May;20(5):645-647. doi: 10.1080/14787210.2022.2012154. Epub 2021 Dec 13. Expert Rev Anti Infect Ther. 2022. PMID: 34894986 No abstract available.
4,974 results